Polymer particles
US-2017081450-A1 · Mar 23, 2017 · US
US9938367B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9938367-B2 |
| Application number | US-201715630048-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 22, 2017 |
| Priority date | Sep 19, 2013 |
| Publication date | Apr 10, 2018 |
| Grant date | Apr 10, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Biodegradable, cross-linked polymer particle embolics and methods of making the same are described. The particle embolics can be used as embolization agents.
Opening claim text (preview).
We claim: 1. An embolic system including: a delivery device; and an embolic solution including polymer particles, wherein the polymer particles include: an acrylate, acrylamide, methacrylamide, methyl methacrylate, or a combination thereof, and a crosslinker, wherein the polymer particles have a spherical diameter between about 40 μm and about 1,200 μm. 2. The embolic system of claim 1 , wherein the polymer particles are susceptible to degradation through hydrolysis or enzymatic action, and wherein the degradation provides less than about 10% of the polymer particles intact after about 5 days. 3. The embolic system of claim 1 , wherein the spherical diameter is between about 75 μm and about 1,200 μm. 4. The embolic system of claim 1 , wherein the crosslinker includes at least two functional groups. 5. The embolic system of claim 1 , wherein the crosslinker includes at least one linkage susceptible to degradation through hydrolysis or enzymatic action. 6. The embolic system of claim 1 , wherein the crosslinker is bis-glycidyl amino alcohol, wherein a, b, c, d, e, and f are each independently 1-20. 7. The embolic system of claim 5 , wherein the at least one linkage is an ester, a thioester, a carbonate, a peptide cleavable by matrix metalloproteinases, a peptide cleavable by matrix collagenases, a peptide cleavable by matrix elastases, a peptide cleavable by matrix cathepsins, or a combination thereof. 8. The embolic system of claim 1 , including a second crosslinker including a second linkage selected from an ester, a thioester, a carbonate, a peptide cleavable by matrix metalloproteinases, a peptide cleavable by matrix collagenases, a peptide cleavable by matrix elastases, and a peptide cleavable by matrix cathepsins. 9. The embolic system of claim 1 , wherein the crosslinker is bis-glycidyl amino alcohol or bi-functionalized methacryloyl-Ala-Pro-Gly-Leu-AEE-methacrylate. 10. The embolic system of claim 1 , wherein the delivery device is a catheter. 11. The embolic system of claim 1 , wherein the delivery device is a microcatheter. 12. The embolic system of claim 1 , wherein the delivery device is a needle. 13. The embolic system of claim 1 , wherein the delivery device and the embolic solution are sterilized. 14. The embolic system of claim 1 , wherein the embolic solution includes a monomer including an ionizable functional group. 15. The embolic system of claim 14 , wherein the ionizable functional group is basic or acidic. 16. The embolic system of claim 1 , wherein the embolic solution includes a radiopaque contrast agent. 17. The embolic system of claim 1 , wherein the embolic solution includes a dye. 18. The embolic system of claim 1 , wherein the embolic solution is provided in a vial. 19. The embolic system of claim 1 , wherein the embolic solution is provided in a syringe. 20. The embolic system of claim 1 , wherein the polymer particles have a circularity greater than about 0.9.
substituted imides comprising other heteroatoms · CPC title
Acrylamide; Methacrylamide · CPC title
Nitrogen-containing compounds {(C08K5/0091 takes precedence)} · CPC title
Biodegradable · CPC title
Particulate matter [e.g., sphere, flake, etc.] · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.